Activity Survey and Historical Perspective of Autologous Stem Cell Transplantation in Europe

Seminars in Hematology

Volumn 44, Issue 4, 2007, Pages 220-226

  Gratwohl, Alois ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADVANCED CANCER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLON CANCER; DONOR SELECTION; DRUG MEGADOSE; EUROPE; EWING SARCOMA; GEOGRAPHIC DISTRIBUTION; GERM CELL TUMOR; HEALTH SURVEY; HEMOGLOBINOPATHY; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; KIDNEY SARCOMA; LEUKEMIA; MELANOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PATIENT CARE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SIBLING; SOFT TISSUE SARCOMA; SOLID TUMOR; TREATMENT INDICATION;

AUTOIMMUNE DISEASES; BLOOD CELLS; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; EUROPE; HEALTH SURVEYS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY, 20TH CENTURY; HUMANS; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; TISSUE DONORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 35348960444     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2007.09.001     Document Type: Article

References (38)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 354 (2006) 1813-1826
2. Thomas E.D. The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1990. Bone marrow transplantation-Past, present and future. Scand J Immunol 39 (1994) 339-345
3. Thomas E.D., Storb R., Clift R.A., Fefer A., Johnson L., Neiman P.E., et al. Bone-marrow transplantation (second of two parts). N Engl J Med 292 (1975) 895-902
4. Mathe G. Hematopoietic cell grafts and their applications. Presse Med 72 (1964) 2391-2394
5. Lorenz E., Uphoff D., Reid T.R., and Shelton E. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 12 (1951) 197-201
6. Gatti R.A., Meuwissen H.J., Allen H.D., Hong R., and Good R.A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2 (1968) 1366-1369
7. Bach F.H., Albertini R.J., Joo P., Anderson J.L., and Bortin M.M. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2 (1968) 1364-1366
8. Gratwohl A., and Hermans J. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT). Clin Transplant 9 (1995) 355-363
9. Gorin N.C., Herzig G., Bull M.I., and Graw Jr. R.G. Related Articles, Long-term preservation of bone marrow and stem cell pool in dogs. Blood 51 (1978) 257-265
10. Bowles C.A., Bull M., McCormick K., Kadin M., and Lucas D. Autologous bone marrow transplantation following chemotherapy and irradiation in dogs with spontaneous lymphomas. J Natl Cancer Inst 65 (1980) 615-620
11. Appelbaum F.R., and Buckner C.D. Overview of the clinical relevance of autologous bone marrow transplantation. Clin Haematol 15 (1986) 1-18
12. Gorin N.C. Autologous bone marrow transplantation in hematological malignancies. Eur J Cancer Clin Oncol 20 (1984) 1-9
13. Buckner C.D., Clift R.A., Fefer A., Neiman P.E., Storb R., and Thomas E.D. Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrow. Exp Hematol 2 (1974) 138-146
14. Goldman J.M., and Deisseroth A.B. Use of autotransplants in chronic myeloid leukaemia. Bone Marrow Transplant 10 suppl 1 (1992) 74-76
15. Reiffers J., Trouette R., Marit G., Montastruc M., Faberes C., Cony-Makhoul P., et al. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: A report of 47 cases. Br J Haematol 77 (1991) 339-345
16. Philip T., Armitage J.O., Spitzer G., Chauvin F., Jagannath S., Cahn J.Y., et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316 (1987) 1493-1498
17. Lippman M.E. High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer. N Engl J Med 342 (2000) 1119-1120
18. McCarthy M. Unproven breast-cancer therapy widely used in USA. Lancet 347 (1996) 1617
19. Farquhar C, Basser R, Marjoribanks J, Lethaby A: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Database Syst Rev (1):CD003139, 2003. Update in Cochrane Database Syst Rev (3):CD003139, 2005
20. Attal M., Harousseau J.L., Facon T., Guilhot F., Doyen C., Fuzibet J.G., et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349 (2003) 2495-2502
21. Harousseau J.L., Attal M., Divine M., Marit G., Leblond V., Stoppa A.M., et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French Registry on Autologous Transplantation in Multiple Myeloma. Blood 85 (1995) 3077-3085
22. Milpied N., Deconinck E., Gaillard F., Delwail V., Foussard C., Berthou C., et al. Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 350 (2004) 1287-1295
23. Vignot S., Mounier N., Larghero J., Brice P., Quero L., de Bazelaire C., et al. High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma: A study using patients as their own controls. Cancer 109 (2007) 60-67
24. Philip T., and Biron P. High-dose chemotherapy and autologous bone marrow transplantation in diffuse intermediate- and high-grade non-Hodgkin lymphoma. Crit Rev Oncol Hematol 41 (2002) 213-223
25. Thomas X., Suciu S., Rio B., Leone G., Broccia G., Fillet G., et al. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: Results of the prospective EORTC-GIMEMA AML-13 study. Haematologica 92 (2007) 389-396
26. de Witte T., Brand R., van Biezen A., Delforge M., Biersack H., Or R., et al., MDS subcommittee of the EBMT Chronic Leukemia Working Party. The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes. Haematologica 91 (2006) 750-756
27. Breems D.A., Boogaerts M.A., Dekker A.W., Van Putten W.L., Sonneveld P., Huijgens P.C., et al. Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: A prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial. Br J Haematol 128 (2006) 59-65
28. Gratwohl A. Bone marrow transplantation activity in Europe 1990. European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 8 (1991) 197-201
29. Gratwohl A., Baldomero H., Frauendorfer K., Urbano-Ispizua A., Niederwieser D., Joint Accreditation Committee of the International Society for Cellular Therapy ISCT, and European Group for Blood and Marrow Transplantation EBMT. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: Focus on increasing use of unrelated donors. Bone Marrow Transplant 39 (2007) 71-87
30. Dazzi F., van Laar J.M., Cope A., and Tyndall A. Cell therapy for autoimmune diseases. Arthritis Res Ther 9 (2007) 206
31. Gratwohl A., Passweg J., Bocelli-Tyndall C., Fassas A., van Laar J.M., Farge D., et al., Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 35 (2005) 869-879
32. Gratwohl A., Baldomero H., Schmid O., Horisberger B., Bargetzi M., and Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: A report of the EBMT activity survey 2003. Bone Marrow Transplant 36 (2005) 575-590
33. Gratwohl A., Baldomero H., Horisberger B., Schmid C., Passweg J., Urbano-Ispizua A., and Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in hematopoietic stem cell transplantation in Europe. Blood 100 (2002) 2374-2386
34. Gratwohl A., Baldomero H., Demirer T., Rosti G., Dini G., Ladenstein R., et al., Accreditation Committee, European Group for Blood and Marrow Transplantation, Working Party on Pediatric Diseases, Working Party on Solid Tumors. Hematopoetic stem cell transplantation for solid tumors in Europe. Ann Oncol 15 (2004) 653-660
35. Gratwohl A., Baldomero H., Passweg J., Frassoni F., Niederwieser D., Schmitz N., et al., Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT), Working Parties Acute (ALWP) Chronic Leukemias (CLWP), Lymphoma Working Party. Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 17 (2003) 941-959
36. Gratwohl A., Passweg J., Baldomero H., Horisberger B., Urbano-Ispizua A., and Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol 117 (2002) 451-468
37. Gratwohl A., Baldomero H., Schwendener A., Gratwohl M., Urbano-Ispizua A., and Frauendorfer K. Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe-Impact of cost considerations. Leukemia 21 (2007) 383-386
38. Gajewski J.L., and Robinson P. Do affluent societies have the only options for the best therapy?. Leukemia 21 (2007) 387-388